61 related articles for article (PubMed ID: 27538133)
1. [Expression of MEK/ERK signal pathways in renal cell carcinoma with bone metastasis].
Qin CP; Liu CL; Zhao YH; Yin HQ; DU YQ; Hu FZ; Sheng ZZ; Xu T
Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Feb; 48(1):590-3. PubMed ID: 27538133
[TBL] [Abstract][Full Text] [Related]
2. [Expression of MEK/ERK signal pathways in renal cell carcinoma with bone metastasis].
Qin CP; Liu CL; Zhao YH; Yin HQ; DU YQ; Hu FZ; Sheng ZZ; Xu T
Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Aug; 48(4):590-593. PubMed ID: 29263494
[TBL] [Abstract][Full Text] [Related]
3. SOX9 was involved in TKIs resistance in renal cell carcinoma via Raf/MEK/ERK signaling pathway.
Li XL; Chen XQ; Zhang MN; Chen N; Nie L; Xu M; Gong J; Shen PF; Su ZZ; Weng X; Tan JY; Zhao T; Zeng H; Zhou Q
Int J Clin Exp Pathol; 2015; 8(4):3871-81. PubMed ID: 26097571
[TBL] [Abstract][Full Text] [Related]
4. Protein kinase C alpha trigger Ras and Raf-independent MEK/ERK activation for TPA-induced growth inhibition of human hepatoma cell HepG2.
Wen-Sheng W
Cancer Lett; 2006 Jul; 239(1):27-35. PubMed ID: 16169661
[TBL] [Abstract][Full Text] [Related]
5. Analysis of invasion-metastasis mechanism in pancreatic cancer: involvement of tight junction transmembrane protein occludin and MEK/ERK signal transduction pathway in cancer cell dissociation.
Tan X; Tamori Y; Egami H; Ishikawa S; Kurizaki T; Takai E; Hirota M; Ogawa M
Oncol Rep; 2004 May; 11(5):993-8. PubMed ID: 15069537
[TBL] [Abstract][Full Text] [Related]
6. [Relationship between raf kinase inhibitor protein and metastasis of ovarian carcinoma].
Wang Y; Yang J; Gao Y; Zhao XL; Li HZ; Yao Z
Zhonghua Fu Chan Ke Za Zhi; 2009 Jul; 44(7):522-8. PubMed ID: 19957553
[TBL] [Abstract][Full Text] [Related]
7. MEK/ERK signaling pathway is required for enterovirus 71 replication in immature dendritic cells.
Shi W; Hou X; Peng H; Zhang L; Li Y; Gu Z; Jiang Q; Shi M; Ji Y; Jiang J
Virol J; 2014 Dec; 11():227. PubMed ID: 25548009
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-497 suppresses renal cell carcinoma by targeting VEGFR-2 in ACHN cells.
Pengcheng S; Ziqi W; Luyao Y; Xiangwei Z; Liang L; Yuwei L; Lechen L; Wanhai X
Biosci Rep; 2017 Jun; 37(3):. PubMed ID: 28465356
[TBL] [Abstract][Full Text] [Related]
9. Clinically Viable Gene Expression Assays with Potential for Predicting Benefit from MEK Inhibitors.
Brant R; Sharpe A; Liptrot T; Dry JR; Harrington EA; Barrett JC; Whalley N; Womack C; Smith P; Hodgson DR
Clin Cancer Res; 2017 Mar; 23(6):1471-1480. PubMed ID: 27733477
[No Abstract] [Full Text] [Related]
10. Moxibustion eases chronic inflammatory visceral pain through regulating MEK, ERK and CREB in rats.
Li ZY; Huang Y; Yang YT; Zhang D; Zhao Y; Hong J; Liu J; Wu LJ; Zhang CH; Wu HG; Zhang J; Ma XP
World J Gastroenterol; 2017 Sep; 23(34):6220-6230. PubMed ID: 28974888
[TBL] [Abstract][Full Text] [Related]
11. [Significance of MEK-ERK cascade in the development of human breast carcinoma].
Wang S; Wang S; Zhu X; Zhang J; Qiao X; Ye Y; Liang B; Ma X; Cui Z
Zhonghua Wai Ke Za Zhi; 2002 Mar; 40(3):171-4. PubMed ID: 11955407
[TBL] [Abstract][Full Text] [Related]
12. MEK1/2 inhibitors in the treatment of gynecologic malignancies.
Miller CR; Oliver KE; Farley JH
Gynecol Oncol; 2014 Apr; 133(1):128-37. PubMed ID: 24434059
[TBL] [Abstract][Full Text] [Related]
13. Binimetinib inhibits MEK and is effective against neuroblastoma tumor cells with low NF1 expression.
Woodfield SE; Zhang L; Scorsone KA; Liu Y; Zage PE
BMC Cancer; 2016 Mar; 16():172. PubMed ID: 26925841
[TBL] [Abstract][Full Text] [Related]
14. [Future targeting of the RAS/RAF/MEK/ERK signaling pathway in oncology: the example of melanoma].
Favre G
Bull Acad Natl Med; 2014 Feb; 198(2):321-36; discussion 337-8. PubMed ID: 26263707
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor β and Ras/MEK/ERK signaling regulate the expression level of a novel tumor suppressor Lefty.
Miyata N; Azuma T; Hozawa S; Higuchi H; Yokoyama A; Kabashima A; Igarashi T; Saeki K; Hibi T
Pancreas; 2012 Jul; 41(5):745-52. PubMed ID: 22441145
[TBL] [Abstract][Full Text] [Related]
16. Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance.
McCubrey JA; Steelman LS; Abrams SL; Lee JT; Chang F; Bertrand FE; Navolanic PM; Terrian DM; Franklin RA; D'Assoro AB; Salisbury JL; Mazzarino MC; Stivala F; Libra M
Adv Enzyme Regul; 2006; 46():249-79. PubMed ID: 16854453
[TBL] [Abstract][Full Text] [Related]
17. Sorafenib blocks the RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5.
Liu L; Cao Y; Chen C; Zhang X; McNabola A; Wilkie D; Wilhelm S; Lynch M; Carter C
Cancer Res; 2006 Dec; 66(24):11851-8. PubMed ID: 17178882
[TBL] [Abstract][Full Text] [Related]
18. ROS production induced by BRAF inhibitor treatment rewires metabolic processes affecting cell growth of melanoma cells.
Cesi G; Walbrecq G; Zimmer A; Kreis S; Haan C
Mol Cancer; 2017 Jun; 16(1):102. PubMed ID: 28595656
[TBL] [Abstract][Full Text] [Related]
19. Induction of beta3-integrin gene expression by sustained activation of the Ras-regulated Raf-MEK-extracellular signal-regulated kinase signaling pathway.
Woods D; Cherwinski H; Venetsanakos E; Bhat A; Gysin S; Humbert M; Bray PF; Saylor VL; McMahon M
Mol Cell Biol; 2001 May; 21(9):3192-205. PubMed ID: 11287623
[TBL] [Abstract][Full Text] [Related]
20. Serine protease inhibitor Kazal type 1 (SPINK1) downregulates E-cadherin and induces EMT of hepatoma cells to promote hepatocellular carcinoma metastasis via the MEK/ERK signaling pathway.
Ying HY; Gong CJ; Feng Y; Jing DD; Lu LG
J Dig Dis; 2017 Jun; 18(6):349-358. PubMed ID: 28544403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
